Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

C3 Antikörper

Der Ratte Monoklonal Anti-C3-Antikörper wurde für IP validiert. Er ist geeignet, C3 in Proben von Human zu detektieren.
Produktnummer ABIN1106774

Kurzübersicht für C3 Antikörper (ABIN1106774)

Target

Alle C3 Antikörper anzeigen
C3 (Complement Component 3 (C3))

Reaktivität

  • 109
  • 56
  • 37
  • 5
  • 5
  • 4
  • 3
  • 3
  • 2
  • 1
Human

Wirt

  • 84
  • 44
  • 37
  • 7
  • 7
  • 5
  • 1
Ratte

Klonalität

  • 136
  • 48
Monoklonal

Konjugat

  • 84
  • 27
  • 23
  • 12
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser C3 Antikörper ist unkonjugiert

Applikation

  • 118
  • 51
  • 44
  • 42
  • 37
  • 34
  • 33
  • 30
  • 29
  • 27
  • 22
  • 13
  • 13
  • 9
  • 5
  • 5
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Immunoprecipitation (IP)

Klon

4
  • Kreuzreaktivität (Details)

    Species reactivity (tested):Human

    Aufreinigung

    Protein G

    Isotyp

    IgG2a
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 0.1 % bovine serum albumin

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Store at 2 - 8 °C.
  • Target

    C3 (Complement Component 3 (C3))

    Andere Bezeichnung

    Complement C3

    Hintergrund

    The complement system is an important factor in innate immunity. The third complement component, C3, is central to the classical, alternative and lectin pathways of complement activation. Activation products of the complement cascade contain neo-epitopes that are not present in the individual native components. The synthesis of C3 is tissue-specific and is modulated in response to a variety of stimulatory agents. C3 is the most abundant protein of the complement system with serum protein levels of about 1.3 mg/mL. An inherited deficiency of C3 predisposes the person to frequent bacterial infections. C3 fragments are deposited in tissues at sites of antibody-mediated immunopathology. In ulcerative colitis and idiopathic chronic inflammatory bowel disease, the deposition of C3 in the diseased mucosa has been reported. Proteolysis by C3-convertases results in the cleavage of C3 into C3a and C3b. C3b becomes attached to immune complexes and is further cleaved into iC3b and C3f. iC3b is further processed into C3c and C3dg.Synonyms: C3 and PZP-like alpha-2-macroglobulin domain-containing protein 1, CPAMD1, Complement component 3

    Gen-ID

    9606

    UniProt

    P01024

    Pathways

    Komplementsystem, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Regulation of G-Protein Coupled Receptor Protein Signaling
Sie sind hier:
Chat with us!